Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBIT vs Aripiprazole in Tic Disorders
NCT04765085Withdrawn
- Sponsor
- Children's Hospital of Fudan University
- Start
- Mar 2021
- Primary completion
- Jun 2022
01
Overview
Randomised, open-label trial (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: Reduction rate of Tic symptom severity before and after intervention at 10 weeks. Planned start Mar 2021; status: withdrawn.
Beyond the preview
Go deeper on NCT04765085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04765085.